Entrada Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.90
|
0.00
|
0.90
|
100.00%
|
|
2022-12-31
|
-0.83
|
0.00
|
0.83
|
100.00%
|
|
2022-09-30
|
-0.76
|
-0.80
|
-0.04
|
-5.26%
|
|
2022-06-30
|
-0.72
|
-0.74
|
-0.02
|
-2.78%
|
|
2022-03-31
|
-0.65
|
-0.69
|
-0.04
|
-6.15%
|
|
2021-12-31
|
-1.28
|
-0.89
|
0.39
|
30.47%
|
|
2021-09-30
|
-0.87
|
-9.78
|
-8.91
|
-1024.14%
|
|
2021-06-30
|
0.00
|
-0.45
|
-0.45
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.23
|
|
2021-12-31
|
-18.20
|
|
2020-12-31
|
-12.26
|
|
2019-12-31
|
-5.18
|